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doi:10.1016/j.kjms.2011.03.002Abstract This large-scale prospective cohort study of a Taiwan population applied general-
ized estimating equations to evaluate predictors of health-related quality of life (HRQOL)
after open cholecystectomy (OC) and laparoscopic cholecystectomy (LC) procedures per-
formed between February 2007 and November 2008. The Gastrointestinal Quality of Life
Index and Short Form-36 were used in a preoperative assessment and in 3rd month and 6th
month postoperative assessments of 38 OC and 259 LC patients. The HRQOL of the cholecys-
tectomy patients were significantly improved at 3 months and 6 months postsurgery
(p < 0.05). At 3 months postsurgery, HRQOL improvement was significantly larger in LC
patients than in OC patients. Patient characteristics, clinical characteristics, and health care
quality were also significantly related to HRQOL improvement (p< 0.05). Additionally, after
controlling for related variables, preoperative health status was significantly and positively
associated with each subscale of the Gastrointestinal Quality of Life Index and Short Form-
36 throughout the 6 months (p< 0.05). Patients should be advised that their postoperative
HRQOL may depend not only on their postoperative health care but also on their preoperative
functional status.
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Cholecystectomy can be categorized as open cholecystec-
tomy (OC) or laparoscopic cholecystectomy (LC). The first
LC was performed by Pillipe Mouret in France in 1987. In
Western countries, more than 75% of patients who suffer
from cholelithiasis combined with acute or chronic chole-
cystitis undergo LC surgery [1], and about 6,000 patients
undergo LC surgery annually in Taiwan. This procedure is
now a standard treatment for cholelithiasis because of its
short operation time, minimal invasiveness, good patient
tolerance, rapid recovery, and short hospitalization time
[2e4].
Health-related quality of life (HRQOL) is a critical
consideration when evaluating treatment options for
cholelithiasis. Therefore, understanding the postoperative
physical, psychological, and social outcomes associated
with cholecystectomy is essential [5,6]. When evaluating
HRQOL outcomes, especially after cholecystectomy, accu-
rate data collection by longitudinal survey is essential
[5e7]. Accurately evaluating treatment efficacy generally
requires a generic outcome measure, such as a general
HRQOL improvement and a disease-specific measure of
clinical improvement.
Until now, most studies of cholecystectomy outcome
have only evaluated patients at 3 months postoperatively
after they had received only one or two postoperative
assessments [4e6]. Additionally, studies of treatment effi-
cacy in patients who have received cholecystectomy in
countries elsewhere have been limited to procedures per-
formed in only one medical institution [7]. Hence, this
follow-up study focused on dimensions, such as patient
demographics, clinical characteristics, health care quality,
and preoperative health status to provide guidance in
performing related medical treatments and to establish
reliable HRQOL measures. Longitudinal changes in each
HRQOL subscale were evaluated in terms of predictive
value for cholecystectomy outcome. This study is, to our
knowledge, the first to apply generalized estimating
equations (GEEs) in a large-scale prospective cohort study
of HRQOL change and predictors in a Taiwan population of
cholecystectomy patients.
Materials and methods
Participants and data collection
The participants of this study were patients who had
received OC or LC at two southern Taiwan medical centers
between February 2007 and November 2008. For accurate
assessment of postoperative outcome measures, only
patients who had been treated by highly experienced
surgeons were analyzed [8]. That is, the participants were
patients who had undergone cholecystectomy performed
by directors of surgery in a medical institution or by senior
attending doctors specializing in cholecystectomy surgery
or treatment. Inclusion criteria were the following: (1)
history of OC or LC after initial diagnosis of cholelithiasis
alone; (2) ability to communicate in Chinese and Taiwa-
nese; and (3) agreement to participate in questionnaire
survey in the hospital ward or by telephone. Exclusioncriteria were postoperative diagnosis of any disease other
than cholelithiasis or polyp and failure to complete post-
operative questionnaires. The final study population of 297
patients included 38 OC patients and 259 LC patients.
Patient characteristics (including age, gender, education
level, marital status, and body mass index (BMI), Charlson
comorbidity index (CCI), history of abdominal surgery,
duration of illness, reason for surgery, administration type,
history of tobacco, and alcohol use), clinical characteristics
(including duration of surgery and classification of anes-
thetic risk), health care quality [including rehospitalization
within 30 days postsurgery, average length of stay (ALOS),
and complications], and preoperative health status were
collected through structured questionnaires and by review
of patient records. All involved institutions approved this
study of human subjects before initiating the survey.
Measures of HRQOL
The Gastrointestinal Quality of Life Index (GIQLI) was
administered to evaluate social function and psychological
and physical symptoms. The Short Form-36 (SF-36) Health
Survey was administered to assess self-reported general
health preoperatively and at 3 months and 6 months
postsurgery.
The GIQLI gives a total score based on scores for four
dimensions: symptoms, emotional function, physical func-
tion, and social function. The index includes 35 four-point
questions with a maximum score of 140, where higher
scores represent better health conditions postoperatively.
The SF-36 measures eight dimensions: physical (PF), role
physical (RP), bodily pain (BP), general health (GH), vitality
(VT), social functioning (SF), role emotional (RE), and
mental health (MH). The maximum score for each dimen-
sion is 100, and higher scores indicate better postoperative
health conditions. The SF-36 also includes a physical
component summary dimension and a mental component
summary dimension. Based on the formula suggested by
Ware [9] and on nationwide data collected by researchers
in Taiwan [10], each score was converted to obtain a mean
of 50 and a standard deviation of 10. Briefly, physical
component summary or mental component summary scores
higher than 50 and lower than 50 indicated better and
worse general bodily or psychological function, respec-
tively, compared with the “nationwide” normal group.
Statistical analysis
The unit of analysis in this study was the individual patient.
The data structure of the sample was first established by
statistical analysis of demographic data. Improved post-
operative outcomes in different dimensions were then
assessed by calculating effect size (ES). Improved post-
operative HRQOL at each time point was analyzed by GEE
modeling. Risk factors that significantly correlated with
outcome dimensions or variables were identified by
univariate analysis. The related risk factors were then
entered into the GEE model for multivariate regression
analysis as described in the literatures [11e13].
The model was constructed by first performing multiple
regression analyses to find the best predictors of HRQOL at
282 L.-N. Hsueh et al.different time points when using preoperative measures as
baseline. Dependent variables (mean value of each GIQLI
and SF-36 subscale) were modeled as a function of time and
effect predictors. These significant independent variablesTable 1 Demographic and clinical characteristics of participan
Characteristics OC (nZ 38)
Characteristics, mean (SD)
Age 61.47 (15.32
BMI 24.79 (3.78)
Duration of symptoms 5.33 (11.49)
Number of comorbidities 1.58 (1.65)
Gender, n (%)
Male 28 (73.68)
Female 10 (26.32)
Education, n (%)
No formal education 6 (15.79)
Primary school 11 (28.95)
Junior high school 4 (10.53)
Senior high school 4 (10.53)
College 13 (34.21)
Marital status, n (%)
Single d
Married 38 (100.00)
Previous abdominal surgery, n (%)
Yes 15 (39.47)
No 23 (60.53)
Surgical factors, n (%)
Symptomatic gallstones 20 (52.63)
Acute cholecystitis with gallstones 18 (47.37)
Administration type, n (%)
OPD 28 (73.68)
ED 10 (26.32)
Current drinker, n (%)
Yes 8 (21.05)
No 30 (78.95)
Current smoker, n (%)
Yes 9 (23.68)
No 29 (76.32)
Quality of care, mean (SD)
ALOS 9.43 (4.89)
Rehospitalization within 30 days, n (%)
Yes d
No 38 (100.00)
Current complications, n (%)
0 38 (100.00)
1 d
Clinical characteristics, mean (SD)
Operation time 138.68 (62.7
ASA score 2.43 (0.60)
ASAZ American Society of Anesthesiologists; ALOSZ average length
LCZ laparoscopic cholecystectomy; OCZ open cholecystectomy; OPwere further included in the longitudinal analysis. Resta-
ted, these effective predictive variables were included as
covariates in the GEE approach because they were statis-
tically significant in the multivariable models and are thets
LC (nZ 259) Total (nZ 297)
) 53.27 (14.78) 54.32 (15.08)
24.53 (3.67) 24.56 (3.67)
14.45 (34.10) 13.30 (32.27)
0.89 (1.48) 0.98 (1.52)
105 (40.54) 13 (44.78)
154 (59.46) 164 (55.21)
30 (21.62) 36 (12.12)
56 (21.62) 67 (22.55)
35 (13.51) 39 (13.13)
87 (33.59) 91 (30.64)
51 (19.69) 64 (21.55)
36 (13.90) 36 (12.12)
223 (86.10) 164 (87.88)
84 (32.43) 99 (33.33)
175 (67.57) 198 (66.67)
162 (62.55) 182 (61.28)
97 (37.45) 115 (38.72)
195 (75.29) 223 (75.08)
64 (24.71) 74 (24.92)
34 (13.13) 42 (14.14)
225 (86.87) 255 (85.86)
39 (15.06) 48 (16.16)
220 (84.94) 249 (83.84)
4.54 (3.28) 5.16 (3.87)
10 (3.86) 10 (3.37)
249 (96.14) 287 (96.63)
234 (90.35) 272 (91.58)
25 (9.65) 25 (8.42)
8) 85.33 (41.76) 92.15 (48.29)
2.04 (0.64) 2.09 (0.65)
s of stay; BMIZ body mass index; EDZ emergency department;
DZ outpatient department; SDZ standard deviation.
Table 2 HRQOL before and after cholecystectomy (mean SD)
Variable OC LC
Preoperation 3-mo postsurgery (p) 6-mo postsurgery (p) Preoperation 3-mo postsurgery (p) 6-mo postsurgery (p)
GIQLI
Symptom 63.11 2.82 58.90 3.93 (0.290) 72.68 4.33 (0.001) 58.17 0.63 68.42 0.77 (<0.001) 71.14 0.89 (<0.001)
Emotion 14.92 0.82 14.91 0.99 (0.994) 18.52 1.11 (0.001) 13.21 0.24 17.47 0.29 (<0.001) 18.02 0.33 (0.095)
Physical 17.89 1.22 16.60 1.40 (0.357) 22.96 1.57 (<0.001) 18.17 0.32 20.54 0.42 (<0.001) 24.31 0.48 (<0.001)
Social 13.39 0.86 11.17 0.99 (0.026) 16.48 1.12 (<0.001) 8.83 0.16 10.57 0.18 (<0.001) 10.98 0.21 (<0.001)
Total 110.74 5.12 103.49 6.88 (0.292) 132.09 7.60 (<0.001) 100.92 1.26 120.49 1.51 (<0.001) 128.08 1.74 (<0.001)
SF-36
PF 84.53 1.88 89.34 2.46 (0.050) 92.48 2.46 (<0.001) 76.56 1.15 91.13 1.46 (<0.001) 96.27 1.46 (<0.001)
RP 57.61 6.30 57.84 8.62 (0.979) 92.51 8.62 (<0.001) 56.37 1.99 86.49 2.60 (<0.001) 92.02 2.60 (0.033)
RE 72.43 5.26 83.83 6.86 (0.096) 95.17 6.86 (0.098) 54.01 2.10 86.06 2.77 (<0.001) 92.49 2.77 (<0.001)
SF 89.14 2.88 81.58 3.70 (<0.001) 94.52 3.70 (<0.001) 74.61 1.14 87.66 1.34 (<0.001) 91.55 1.34 (<0.001)
BP 52.03 3.23 84.48 4.12 (<0.001) 92.63 4.12 (<0.001) 57.76 1.06 84.06 1.42 (<0.001) 93.26 1.42 (<0.001)
VT 64.47 2.86 69.10 3.57 (0.194) 78.61 3.57 (<0.001) 56.31 1.08 65.99 1.28 (<0.001) 67.36 1.07 (0.285)
MH 75.79 2.54 84.33 2.91 (<0.001) 82.91 2.91 (0.625) 60.73 1.12 70.15 1.17 (<0.001) 73.19 1.17 (<0.001)
GH 57.45 3.05 66.52 3.23 (<0.001) 68.13 3.23 (0.618) 59.60 1.12 66.27 1.19 (<0.001) 73.52 1.19 (<0.001)
PCS 45.15 1.00 51.22 1.38 (<0.001) 51.38 1.38 (0.906) 48.80 0.44 53.95 0.56 (<0.001) 56.47 0.56 (<0.001)
MCS 44.08 2.38 51.00 3.02 (0.022) 48.89 3.02 (0.486) 29.24 1.04 43.07 1.19 (<0.001) 45.96 1.19 (0.015)
BPZ bodily pain; GHZ general health; GIQLIZ gastrointestinal quality of life index; HRQOLZ health-related quality of life; LCZ laparoscopic cholecystectomy; MCSZmental
component summary; MHZmental health; OCZ open cholecystectomy; PCSZ physical component summary; PFZ physical function; REZ role emotional; RPZ role physical;
SFZ social function; SF-36Z Short-Form 36 Health Survey; VTZ vitality.
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284 L.-N. Hsueh et al.conventional HRQOL predictors applied in the literature
[11e13]. The GEE procedure under XTGEE in Stata, version
9.0 (StataCorp, College Station, TX, USA), was used for
statistical analyses in this study.Results
In the 297 cholelithiasis patients analyzed in this study,
average age was 54.32 15.08 years, average BMI was
24.56 3.67 kg/m2, average illness duration was 13.30
32.27 months, and average CCI was 0.98 1.52. Of the
analyzed patients, 55.21% were female, 30.64% had a high
school education or above, 87.88% were married, 66.67% had
ahistory of abdominal surgery, 61.28%hada history of surgery
for symptomatic cholelithiasis, 75.08% had been treated in
clinics, 85.86% were drinkers, 83.84% were smokers, 96.63%
did not require rehospitalization within 30 days, and 91.58%
had no complications. ALOS was 5.16 3.87 days, average
surgery duration was 92.15 48.29 minutes, and average
anesthetic risk classification was 2.09 0.65 (Table 1).
By 3 months postsurgery, the OC patients had signifi-
cantly (p< 0.05) improved in GIQLI social score; and, by
6 months postsurgery, they had significantly (p< 0.05)
improved in other dimensions as well. The LC patients,
however, exhibited significant improvement in all dimen-
sions at both 3 months and 6 months postsurgery (p< 0.05)
(Table 2). By 3 months postsurgery, the OC patients had
significantly improved in all SF-36 dimensions except for RP,
VT, and RE. By 6 months postsurgery, the OC patients had
significantly (p< 0.05) improved in all dimensions. The LC
patients, however, exhibited significant improvement in all
dimensions at both 3 months and 6 months postsurgeryTable 3 Effect sizes of HRQOL in different time sequences bef
Variables OC
Preoperatively vs.
3-mo postsurgery
3-mo postsurgery
6-mo postsurge
GIQLI
Symptom 1.49 3.51
Emotion 0.01 3.65
Physical 1.06 4.54
Social 2.58 5.36
Total 1.42 4.16
SF-36
PF 2.56 1.28
RP 0.04 4.02
RE 2.17 1.65
SF 2.63 3.50
BP 10.05 1.98
VT 1.62 2.66
MH 3.36 0.49
GH 2.97 0.50
PCS 6.07 0.11
MCS 2.91 0.70
BPZ bodily pain; GHZ general health; GIQLIZ gastrointestinal q
LCZ laparoscopic cholecystectomy; MCSZmental component s
PCSZ physical component summary; PFZ physical function; RE
SF-36Z Short-Form 36 Health Survey; VTZ vitality.(p< 0.05). Additionally, patients who had complications in
LC and those who did not have any complications
throughout the 6 months did not statistically differ in
preoperative or in any of the aforementioned postoperative
HRQOL parameters (data not shown).
Table 3 compares the HRQOL improvement between OC
and LC in different dimensions and time points. The OC
patients exhibited negative change in all GIQLI dimensions
at 3 months postsurgery with ES ranging from 0.01
(psychological function) to 2.58 (social function), whereas
all changes were positive at 6 months postsurgery with ES
ranging from 3.51 (symptoms) to 5.36 (social function).
Additionally, the HRQOL changes in LC patients were
uniformly positive at 3 months postsurgery with ES ranging
from 7.41 (physical function) to 17.75 (psychological func-
tion) and also uniformly positive at 6 months postsurgery
with ES ranging from 1.90 (psychological function) to 8.98
(physical function). Analysis of total GIQLI indicated that
the largest HRQOL change occurred at 6 months postsurgery
in OC patients and at 3 months postsurgery in LC patients.
Except for the SF dimension of the SF-36, HRQOL changes in
the OC patients were uniformly positive at 3 months post-
surgery with ES ranging from 2.63 (SF) to 10.05 (BP).
Except for the MH dimension of the SF-36, HRQOL changes
in OC patients were uniformly positive at 6 months post-
surgery with ES ranging from 0.49 (PF) to 4.02 (RP).
Meanwhile, the HRQOL changes in LC patients were
uniformly positive at both 3 months and 6 months post-
surgery with ES ranging from 5.96 (GH) to 24.81 (BP) and
from 1.07 (VT) to 6.48 (BP), respectively.
Table 4 shows the results of multivariate analysis of
effective HRQOL predictors. Each time point was signifi-
cantly related to the GIQLI subscales throughout theore and after cholecystectomy
LC
vs.
ry
Preoperatively vs.
3-mo postsurgery
3-mo postsurgery vs.
6-mo postsurgery
16.27 3.53
17.75 1.90
7.41 8.98
10.88 2.28
15.53 5.03
12.67 3.52
15.14 2.22
15.26 2.32
11.45 2.55
24.81 6.48
8.96 1.07
8.41 2.60
5.96 6.09
11.7 4.50
13.3 2.43
uality of life index; HRQOLZ health-related quality of life;
ummary; MHZmental health; OCZ open cholecystectomy;
Z role emotional; RPZ role physical; SFZ social function;
Table 4 Multivariate regression analysis: factors affecting postoperative HRQOL of patients receiving OC and LC (GIQLI)
Variables OC LC
Symptom
coefficient
Emotion
coefficient
Physical
coefficient
Social
coefficient
Total
coefficient
Symptom
coefficient
Emotion
coefficient
Physical
coefficient
Social
coefficient
Total
coefficient
Intercept 55.21* 15.10* 21.11* 12.94* 104.81* 69.48* 17.14* 24.01* 11.80* 125.67*
Timea
3-mo postsurgery 4.43* 0.12 1.39 2.20* 7.66* 10.27* 4.26* 2.38* 1.74* 19.60*
6-mo postsurgery 9.64* 3.58* 5.22* 3.04* 21.66* 13.23* 4.89* 6.23* 2.18* 27.61*
Gendera
Female 0.86 0.18 2.03 0.67 2.43 1.85 0.71* 0.82 0.40 3.89*
0.5
Age 0.13 0.01 0.03 0.01 0.11 0.05 0.02 0.03* 0.01 0.12
Reason for surgerya
Cholelithiasis combined with
acute cholecystitis
d d d d d 5.58 1.81* 2.64* 1.61* 12.10*
CCI d d d d d 0.55 0.40* 0.24 0.15 1.38
Type of admissiona
Emergency 4.00 0.16 1.53 0.34 5.91 d d d d d
Complicationsa
1 d d d d d 4.30* 1.93 1.07 0.56 8.10*
Average length of stay (d) 0.15 0.04 0.26 0.16 0.36 d d d d d
Anesthesia risk classification 0.01 0.01 0.01 0.01 0.01 d d d d d
Preoperative health status
(GIQLI score)
63.11* 14.92* 17.89* 13.39* 110.74* 58.17* 13.21* 18.17* 8.83* 100.92*
a Reference group: preoperative, male, symptomatic cholelithiasis, clinics, with no complication.
*A p value <0.05.
CCIZ Charlson comorbidity index; GIQLIZ gastrointestinal quality of life index; HRQOLZ health-related quality of life; LCZ laparoscopic cholecystectomy; OCZ open cholecystectomy.
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Table 5 Multivariate regression analysis: factors affecting postoperative QOL in patients receiving OC and LC (SF-36)
Variables OC LC
PF
coefficient
RP
coefficient
RE
coefficient
SF
coefficient
BP
coefficient
VT
coefficient
MH
coefficient
GH
coefficient
PF
coefficient
RP
coefficient
RE
coefficient
SF
coefficient
BP
coefficient
VT
coefficient
MH
coefficient
GH
coefficient
Intercept 108.45* 75.99* 122.34* 83.31* 47.77* 63.71* 83.06* 33.49* 99.05* 71.53* 67.99* 83.23* 63.41* 55.99* 64.95* 54.54*
Timea
3-mo
postsurgery
4.99* 0.23 11.71 7.09 32.71* 5.43 9.31* 9.72* 14.75* 31.33* 33.74* 13.42* 26.64* 9.91* 9.58* 6.54*
6-mo
postsurgery
8.27* 33.35* 23.56* 5.41 40.56* 14.86* 7.49* 10.53* 19.87* 36.32* 38.80* 17.42* 35.95* 11.25* 12.47* 13.38*
Gendera
Female 0.47 0.22 14.72 3.21 1.01 2.07 7.61 5.95 5.45* 9.14* 7.55* 5.72 3.19* 1.74 3.63* 5.02*
Age 0.23* 0.13 0.38 0.13 0.19 0.05 0.09 0.44* 0.25* 0.02 0.06 0.02 0.09 0.12 0.09 0.07
Previous abdominal surgerya
No d d d d d d d d 0.60 0.01 1.53 4.78* 1.52 3.16 1.29 3.61
Reason for
surgerya
d d d d d d d d
Cholelithiasis
combined
with acute
cholecystitis
d d d d d d d d 4.69* 2.41 2.37 1.38 0.63 2.03 4.55* 1.10
BMI 0.01 0.02 0.04* 0.04* 0.02 0.01 0.01 0.01 d d d d d d d d
Educationa
Primary 3.18 5.17 10.74 2.01 10.15 5.35 5.47 7.72 d d d d d d d d
Junior high 1.15 2.89 1.69 0.39 5.14 4.25 4.10 5.89 d d d d d d d d
Senior high 1.97 1.37 0.75 7.37 9.09 16.10* 7.94 27.08* d d d d d d d d
College and
above
5.61 20.83 21.94* 6.48 3.07 4.71 4.96 19.35* d d d d d d d d
Illness duration d d d d d d d d 0.04 0.04 0.09* 0.05* 0.03 0.04 0.08* 0.03
CCI 0.25 2.73 0.75 0.36 2.51 1.04 0.67 3.85* 0.35 1.12* 0.38 0.37 0.84 0.16 0.57 1.16*
Rehospitalization in 30 da
No d d d d d d d d 2.66 4.68 4.26 8.65* 5.37 10.48* 11.07* 7.97
Average length of
stay (d)
0.74* 1.14 0.97 0.23 0.04 0.01 0.20 1.42* 0.41 0.51 0.67 0.16* 0.06 0.09 0.29 0.01
Surgery duration d d d d d d d d 0.01 0.12* 0.08* 0.10 0.04* 0.02 0.07* 0.02
Preoperative
health
status (SF-36
score)
84.53* 57.61* 72.43* 89.14* 52.03* 64.47* 75.79* 57.45* 76.56* 56.37* 54.01* 74.61* 57.76* 56.31* 60.73* 59.60*
a Preoperative characteristics of reference group: male, with history of abdominal surgery, current symptomatic cholelithiasis, no formal education, with rehospitalization in 30 days.
*A p value <0.05.
BMIZ body mass index; BPZ bodily pain; CCIZ Charlson comorbidity indexGHZ general health; LCZ laparoscopic cholecystectomy; MHZmental health; OCZ open cholecystectomy;
PFZ physical function; QOLZ quality of life; REZ role emotional; RPZ role physical; SFZ social function; SF-36Z Short-From 36 Health Survey; VTZ vitality.
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HRQOL in patients undergoing cholecystectomy 2876 months (p< 0.05). After controlling for related variables,
HRQOL revealed a significant and negative association with
female gender, current cholelithiasis combined with acute
cholecystitis, and any current complication. Additionally,
preoperative health status was significantly and positively
associated with each subscale of the GIQLI throughout the 6
months (p< 0.05). Table 5 shows the results. Each time
point was significantly related to the SF-36 subscales
throughout the 6 months (p< 0.05). Female gender;
advanced age; current cholelithiasis combined with acute
cholecystitis; education level lower than junior high school;
rehospitalization within 30 days; and high values for BMI,
CCI, ALOS, and surgery duration were significantly and
negatively associated with HRQOL. Additionally, preopera-
tive health status was significantly and positively associated
with each subscale of the SF-36 throughout the 6 months
(p< 0.05).Discussion
Comparison of HRQOL improvements between different
time points indicated that the GIQLI and SF-36 scores for LC
patients were significantly improved by 6 months post-
surgery. The improvement in LC patients after 6 months
was also much larger than that in OC patients after
6 months, which is consistent with the literatures [11e13].
At 3 months postsurgery, the ES for all GIQLI dimensions
correlated negatively with improvements in OC patients,
which suggests that their health status was relatively
poorer than that at baseline. Possible explanations for the
relatively poorer health status of the OC patients include
their relatively older average age, the larger percentage of
males, the larger percentage of patients with only primary
school education level, and the larger average wound size
[11e13]. The older average age of the OC patients (61.47
years vs. 53.27 years in LC patients) correlated with slower
recovery from surgery, which is consistent with reports that
age is a significant factor in HRQOL [7,11e13].
The baseline scores for the disease-specific measure
(GIQLI) were lower in LC patients than in OC patients. The
average total scores for LC patients were higher than those
of OC patients at 3 months postsurgery, indicating that LC
improvement in general gastrointestinal function is faster
in LC patients than in OC patients. Pain relief and symptom
improvement may also improve bodily function and
emotional function, which may in turn improve social
function [7,12].
Unlike previous reports [11e14], the average duration of
illness in LC patients (14.45 months) was longer than that in
OC patients (5.33 months). Duration of gall bladder disease
is also reportedly shorter after LC than after OC. The data
in this study suggest that gall bladder disease, which
is often accompanied by abdominal pain, is easily mis-
diagnosed as stomach disease, which delays treatment
time. Another possibility is that the poorer health status of
females compared with males causes a cognitive discrep-
ancy in these patients [15,16].
ALOS (9.43 days) for the OC patients in this study was
also longer than that reported in the literature [17]. Car-
bonell et al. [17] found that, compared with females, males
have a longer ALOS (6.6 days) after OC; Steven et al. [18]reported a 7.4-day ALOS after OC whereas Rosenmu¨ller
et al. [19] reported a 7.9-day ALOS after OC. Differences in
national health conditions may explain the discrepancy. An
earlier Taiwan study of cholecystectomy patients reported
that percutaneous transhepatic gallbladder drainage may
be a major cause of increased ALOS [20]. A longer pre-
operation hospital day may also increase ALOS. A final
possibility is that ALOS is longer in Taiwan populations than
in Western populations because of different treatment
protocols or cultural differences.
Although all research questions were satisfactorily
addressed, one limitation should be noted. Prospective data
were collected for a cohort in which the earliest patients
were enrolled in 2007. Therefore, varying follow-up periods
may have caused selection bias. Nonetheless, HRQOL did
not significantly differ between patients who did and did not
complete the entire 6-month study (data not shown).
Additionally, without analyzing long-term HRQOL, it is
unclear whether short-term benefits yield improved long-
term outcomes. Previous studies indicate that sustained
evaluations exceeding 1 year [21,22] are needed to accu-
rately appraise patients who receive cholecystectomy.
The HRQOL improvement was generally larger in LC
patients than in OC patients at 3 months postsurgery,
but both groups had significantly improved by 6 months
postsurgery. In conclusion, factors other than surgical
outcome should be considered when evaluating post-
cholecystectomy quality of life. All the significant factors
identified in this study can be addressed in preoperative
consultations to educate cholecystectomy candidates
regarding the expected course of recovery and functional
outcomes. Medical professionals and families of patients
must also be advised that the HRQOL improvement for
patients who receive such surgeries is determined not
only by the clinical characteristics of the patient and by
the quality of healthcare received but also by preopera-
tive health status. Patients should be advised that post-
operative HRQOL depends on preoperative functional
status and demographic profile.References
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